Last reviewed · How we verify
OC-IgT cells
At a glance
| Generic name | OC-IgT cells |
|---|---|
| Sponsor | Shenzhen Geno-Immune Medical Institute |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Genetically Modified T Cells Against Ovarian Cancer (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |